Literature DB >> 29664448

A review of the bidirectional relationship between psychiatric disorders and diabetes mellitus.

Abdulrahman A Al-Atram1.   

Abstract

The prevalence of type 2 diabetes is rising worldwide, including Saudi Arabia. Among patients with diabetes, 30% suffer from mental disorders, such as depression, schizophrenia, delirium, and substance misuse (for example, tobacco smoking). Moreover, these disorders appear to share a bidirectional relationship with diabetes. For example, the incidence of diabetes has been shown to be 2-4 times greater in patients with schizophrenia than in normal individuals; also, there is a known association between depression and diabetes. In this review, we focus specifically on the bidirectional relationship between diabetes and psychiatric disorders, including the effects of antipsychotic drugs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29664448     DOI: 10.17712/nsj.2018.2.20170132

Source DB:  PubMed          Journal:  Neurosciences (Riyadh)        ISSN: 1319-6138            Impact factor:   0.906


  4 in total

1.  Are laboratory parameter (biomarker) values similar to the healthy volunteer reference range in all patient populations?

Authors:  David A Brott; Michael J Goodman; Richard P Hermann; Michael Merz; Roser Calvo; Nadereh Poorkhalkali; Alexandre Kiazand
Journal:  Drug Des Devel Ther       Date:  2018-09-06       Impact factor: 4.162

2.  The prevalence of type 2 diabetes in people with psychiatric disorders: an umbrella review protocol.

Authors:  N Lindekilde; S Scheuer; F Rutters; J E Henriksen; K H Rubin; M Lasgaard; G S Andersen; F Pouwer
Journal:  Syst Rev       Date:  2020-05-04

3.  Novel hit of DPP-4Is as promising antihyperglycemic agents with dual antioxidant/anti-inflammatory effects for type 2 diabetes with/without COVID-19.

Authors:  Shahenda Mahgoub; Samar S Fatahala; Amira I Sayed; Hanaa B Atya; Mohamed F El-Shehry; Hala Afifi; Samir M Awad; Rania H Abd El-Hameed; Heba Taha
Journal:  Bioorg Chem       Date:  2022-08-10       Impact factor: 5.307

Review 4.  A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes.

Authors:  Sibhghatulla Shaikh; Eun-Ju Lee; Khurshid Ahmad; Syed-Sayeed Ahmad; Jeong-Ho Lim; Inho Choi
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.